Clinical Research

Sickle Cell Is Still A Killer But This 50 Cent Test Could Change That

test, including materials, packaging and labor, is about US$0.50. Hematology for all This device is ...

Article - The Conversation - Sep 2 2014 - 12:09pm

Phase II All-oral Study Of Simeprevir And VX-135 For The Treatment Of Hepatitis C

Medivir AB has announced plans for a phase II proof-of-concept study of an all-oral regimen for ...

Article - News Staff - Nov 3 2012 - 1:00pm

Clinical Trials For Rich Patients Could Help Find Cures For Us All

Institute, Ottawa. All views expressed in this article are those of the author alone. This article was ...

Article - The Conversation - Dec 29 2014 - 8:30am

Vigorous Exercise Is Better Than Moderate Exercise, After All

Yet some exercise is still better than none. The old adage "use it or lose it" is truer than ever. People who maintain a vigorously active lifestyle as they age gain less weight than people who exercise at more moderate levels, according to a fir ...

Article - News Staff - May 3 2007 - 2:54pm

Neanderthal Births Remarkably Similar To Ours (Not All That Easy)

Neanderthals had a brain at birth of a similar size to that of modern-day babies. However, after birth, their brain grew more quickly than it does for Homo sapiens and became larger too. Nevertheless, the individual lifespan ran just as slowly as it does f ...

Article - News Staff - Sep 8 2008 - 10:03pm

New Findings Make Use Of Stem Cells A Little More Complicated

5–6 lineage is generated in all CNS segments, but the genetic pathway leading to Ap cluster formation ...

Article - News Staff - May 23 2010 - 11:08am

Alcohol For A Longer Life?

remains, how does such little ethanol have such an effect on longevity?  "We don't know all the ...

Article - News Staff - Jan 22 2012 - 3:36pm

Clinical Trial Of Intravenous Erwinaze For Acute Lymphoblastic Leukemia

leukemia affects approximately 6,000 Americans, 60 percent of whom are children. ALL is the most common ...

Article - News Staff - Dec 4 2012 - 1:30pm

Acute Lymphocytic Leukemia: Monoclonal Antibody Blinatumomab In Patients With Refractory Disease

achieved a CR/CRh*. All but two patients achieved a molecular response, meaning there was no evidence of ...

Article - Anna Ohlden - Jun 16 2012 - 4:30am

How To Get More Women In Cardiovascular Clinical Trials?

outcomes? No, there is no giant disparity in heart attacks because studies have more men. We're all ...

Article - News Staff - Aug 9 2021 - 3:50pm